Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations

American Journal of Epidemiology
V McGuireA S Whittemore

Abstract

In the general population, ovarian cancer risk is inversely associated with oral contraceptive use, tubal ligation, and childbearing. Among carriers of BRCA1 gene mutations, the data are conflicting. The authors identified women diagnosed with incident invasive epithelial ovarian cancer in the San Francisco Bay Area of California from March 1997 through July 2001. They compared the contraceptive and reproductive histories of 36 carrier cases and 381 noncarrier cases with those of 568 controls identified by random digit dialing who were frequency matched to cases on age and race/ethnicity. In both carriers and noncarriers, reduced risk was associated with ever use of oral contraceptives (odds ratio = 0.54 (95% confidence interval (CI): 0.26, 1.13) for carriers and 0.55 (95% CI: 0.41, 0.73) for noncarriers), duration of oral contraceptive use (risk reduction per year = 13% (p = 0.01) for carriers and 6% (p < 0.001) for noncarriers), history of tubal ligation (odds ratio = 0.68 (95% CI: 0.25, 1.90) for carriers and 0.65 (95% CI: 0.45, 0.95) for noncarriers), and increasing parity (risk reduction per childbirth = 16% (p = 0.26) for carriers and 24% (p < 0.001) for noncarriers). These data suggest that BRCA1 mutation carriers and no...Continue Reading

Citations

May 21, 2005·Gynecologic Oncology·Livia KelemenGeorgia Chenevix-Trench
Oct 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GadducciR Tana
Mar 23, 2011·Human Molecular Genetics·Celeste Leigh PearceAnna H Wu
Jun 15, 2010·Human Reproduction Update·D CibulaL Dusek
Jul 17, 2010·Human Reproduction Update·D CibulaL Dusek
Apr 10, 2013·International Journal of Epidemiology·Weiva SiehUNKNOWN Ovarian Cancer Association Consortium
Mar 12, 2009·Cancer Research·Joellen M SchildkrautUNKNOWN Australian Ovarian Cancer Study Group
Mar 20, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mark H GreeneStephen Skates
Dec 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rachel T PalmieriUNKNOWN Australian Ovarian Cancer Study Group
May 17, 2012·Journal of Ovarian Research·Megan S RiceShelley S Tworoger
Dec 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianSylvia K Plevritis
Mar 5, 2013·Cancer Causes & Control : CCC·Mette T FaberUNKNOWN Ovarian Cancer Association Consortium
Aug 31, 2013·Journal of Women's Health·Daniela L StanJamie N Bakkum-Gamez
Mar 7, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Celeste Leigh PearceUNKNOWN Ovarian Cancer Association Consortium
Jul 17, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Angiolo GadducciAndrea Riccardo Genazzani
Feb 7, 2016·Cancer Epidemiology·Camilla PræstegaardUNKNOWN Ovarian Cancer Association Consortium
May 30, 2012·Obstetrics and Gynecology Clinics of North America·Lori L Ballinger
Jan 17, 2012·Hematology/oncology Clinics of North America·Laura L Holman, Karen H Lu
Aug 20, 2010·Gynecologic Oncology·Danielle VicusSteven A Narod
Jun 12, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S IodiceS Gandini
May 11, 2010·Gynecologic Oncology·Danielle VicusUNKNOWN Hereditary Ovarian Cancer Clinical Study Group
Mar 25, 2009·Gynecologic Oncology·UNKNOWN ACOG Committee on Practice Bulletins
Dec 7, 2007·Obstetrics and Gynecology Clinics of North America·Christine Vo, Michael E Carney
Oct 18, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Bengt KällénUlla-Britt Wennerholm
May 8, 2013·International Journal of Cancer. Journal International Du Cancer·Megan S RiceKathryn L Terry
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Galina LurieUNKNOWN Ovarian Cancer Association Consortium
Mar 18, 2006·Best Practice & Research. Clinical Obstetrics & Gynaecology·Gudrun Rieck, Alison Fiander
Dec 22, 2005·Best Practice & Research. Clinical Obstetrics & Gynaecology·Louise Hanna, Malcolm Adams
Mar 31, 2015·Cancer·Otis W Brawley
Jul 8, 2015·British Journal of Cancer·C M NagleUNKNOWN Ovarian Cancer Association Consortium
Aug 23, 2008·Gynecologic Oncology·Aasia SaleemuddinShelley Tworoger
Dec 21, 2013·Gynecologic Oncology·Christine GarciaC Bethan Powell
Dec 3, 2014·Journal de gynécologie, obstétrique et biologie de la reproduction·M JéguJ Levêque
Oct 5, 2016·American Journal of Epidemiology·Merlise A ClydeUNKNOWN , on behalf of the Ovarian Cancer Association Consortium
Nov 3, 2009·Best Practice & Research. Clinical Obstetrics & Gynaecology·Grigoris F Grimbizis, Basil C Tarlatzis
Nov 18, 2016·International Journal of Environmental Research and Public Health·Chunpeng WangShuang Li
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia G MoormanEvan R Myers
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M BrohetMatti A Rookus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.